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Background:  Atrial fibrillation (AF) is common in patients (pts) referred for mitral valve (MV) surgery (15-40%). The outcome of pts with AF and 
valve disease is inferior following surgery. The STS database suggests that in many pts AF is left untreated due to perceived risk and complexity. This 
study examined the impact of the Cox Maze III (CMIII) procedure on short and long term outcome in pts following MV surgery.
Methods:  This prospective study examined morbidity and mortality in pts having surgeries that included the MV since 2005 (N=229). Of those, 
124 had concomitant CMIII and 105 did not have CMIII. Mean follow-up was 36 months. Propensity score matching with a 0.25 caliper was used to 
simulate randomization and 91 pts with CMIII were matched to 91 without.
Results:  The two groups were similar on pt characteristics such as age, gender, and EuroSCORE. There were no operative deaths. The CMIII pts had 
similar incidence of complications, 30 day readmissions (10% vs 15%), and long term mortality (4% vs 4%) versus the pts without CMIII. Survival was 
also similar (p=0.89; Fig). The CMIII pts had less perioperative AF versus pts without CMIII (2% vs 19%, p<0.001). At 1 year 85% (57/67) of CMIII pts 
were in sinus rhythm.
Conclusion: The addition of the Cox Maze III procedure did not confer additional surgical risk or decreased survival and had the advantage of 
high return to sinus rhythm. Surgical ablation should not be denied to patients who present for MV surgery with AF only due to concerns related to 
surgical complexity and risk. 
